All Pharma News
Enforcement Report - Week of February 28, 2024

Enforcement Report - Week of February 28, 2024
FDA
28 Feb 2024
Share Share
Enforcement Report - Week of January 24, 2024

Enforcement Report - Week of January 24, 2024
FDA
24 Jan 2024
Share Share
Enforcement Report - Week of September 13, 2023

Enforcement Report - Week of September 13, 2023
FDA
13 Sep 2023
Share Share
Enforcement Report - Week of July 26, 2023

Enforcement Report - Week of July 26, 2023
FDA
26 Jul 2023
Share Share
Ascend launches with $130M+ as it looks to build in the AAV space

Ascend launches with $130M+ as it looks to build in the AAV space
Tyler Patchen ENDPTS
09 May 2023
Share Share
Enforcement Report - Week of April 26, 2023

Enforcement Report - Week of April 26, 2023
FDA
26 Apr 2023
Share Share
Enforcement Report - Week of April 5, 2023

Enforcement Report - Week of April 5, 2023
FDA
05 Apr 2023
Share Share
Ascend Labs recalls anticoagulant pills on carcinogen concerns

Ascend Labs recalls anticoagulant pills on carcinogen concerns
Joseph Keenan FIERCE PHARMA
23 Mar 2023
Share Share
Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitroso-dabigatran (NDAB) Impurity

Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitroso-dabigatran (NDAB) Impurity
FDA
22 Mar 2023
Share Share
Enforcement Report - Week of February 1, 2023

Enforcement Report - Week of February 1, 2023
FDA
01 Feb 2023
Share Share